CPHL · Citi Pharma Ltd.
Citi Pharma Limited Board Meeting Notice for Quarter Ended Sep 30, 2026
Official PSX filing title: Board Meeting
- Filed
- 23 October 2026 at 10:22 am
- Category
- Meetings
- Sentiment
- Neutral
- Impact
- Low
Executive summary
Citi Pharma Limited has announced that a meeting of its Board of Directors will be held on October 30, 2026, to consider the un-audited unconsolidated and consolidated financial statements for the quarter ended September 30, 2026. A closed period is in effect from October 24, 2026, to October 30, 2026.
Key takeaways
- Board meeting scheduled for October 30, 2026
- To review financial results for the period ended September 30, 2026
- Closed period declared from October 24, 2026, to October 30, 2026
Filing details
Board meeting
- Status
- Scheduled
- Meeting date
- 30 October 2026 at 4:00 pm
- Purpose
- To consider financial results for the quarter ended September 30, 2026
- Venue
- Head office situated at 588, Q-Block, Johar Town, Lahore, Lahore
- Closed period
- 24 October 2026 – 30 October 2026
- Consider and approve the Un-audited Unconsolidated and Consolidated Condensed Interim Financial Statements for the Quarter ended September 30, 2026
- Transact any other business with the permission of the Chair
- #board meeting
- #financial results
- #quarterly results
- #closed period
Please cross-check with the official PSX filing before making an investment decision.